In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity

Ítems similars

• In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity
  per: Joanna Matalińska, et al.
  Publicat: (2020-10-01)
• Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus
  per: Dyniewicz, Jolanta, et al.
  Publicat: (2020)
• Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
  per: Halik, Paweł K., et al.
  Publicat: (2020)
• Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis
  per: Lipiński, Piotr F. J., et al.
  Publicat: (2019)
• β(2)-Homo-Amino Acid Scan of µ-Selective Opioid Tetrapeptide TAPP
  per: Tymecka, Dagmara, et al.
  Publicat: (2020)